Biotin

CHEMBL857 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
244.3 g/mol
LogP
0.3
Phase
4

A water-soluble B vitamin essential for enzymes involved in fat, carbohydrate, and protein metabolism. It is used to treat or prevent biotin deficiency and is found in many nutritional supplements marketed for hair, skin, and nail health. True deficiency is rare but can occur with prolonged raw egg white consumption or certain inherited metabolic disorders.

分子量

244.3100 g/mol

LogP

0.30

TPSA

104.00 Ų

リピンスキーの五則

適合

治療領域

作用機序

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

InChI

InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1

Molecular Formula

C10H16N2O3S

HBD / HBA

3 / 4

回転可能結合数

5

重原子数

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A water-soluble B vitamin essential for enzymes involved in fat, carbohydrate, and protein metabolism. It is used to treat or prevent biotin deficiency and is found in many nutritional supplements marketed for hair, skin, and nail health. True deficiency is rare but can occur with prolonged raw egg white consumption or certain inherited metabolic disorders.

Selectively blocks angiotensin II type 1 (AT1) receptors, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduced sodium retention, and decreased blood pressure.

Yes, Biotin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL857. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 171548. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.